Buraschi Cristina
About Buraschi Cristina
Buraschi Cristina is a Sales Manager Cardiovascular at Bristol-Myers Squibb with over 25 years of experience in the pharmaceutical industry, including extensive roles in both the Italian and American markets.
Current Title and Role
Cristina Buraschi is currently working as the Sales Manager for Cardiovascular at Bristol-Myers Squibb. She transitioned to this role in 2017 after serving as the Sales Manager for Virology within the same company. Her extensive tenure at Bristol-Myers Squibb underscores her deep expertise and commitment to the pharmaceutical industry.
Career Progression at Bristol-Myers Squibb
Cristina Buraschi has held multiple roles at Bristol-Myers Squibb, showcasing a robust career progression. She was the Sales Manager for Virology from 2014 to 2017 in New York, New York, United States. Prior to this, she served as a Product Specialist for 11 years from 2003 to 2014. She began her career at Bristol-Myers Squibb as an ISF Cardiovascolare from 2000 to 2002, spanning a total period at the company that exceeds two decades.
Early Career Experience
Before joining Bristol-Myers Squibb, Cristina Buraschi worked at AstraZeneca as an Informator medico scientifico for eight years from 1992 to 2000. She also spent nine months at Nativelle in the same role from 1991 to 1992. These positions reflect her long-standing involvement in the pharmaceutical industry.
Educational Background
Cristina Buraschi studied at Liceo Scientifico, establishing a strong foundation in scientific education. She further pursued higher education at Università degli Studi di Milano, which has equipped her with the knowledge and credentials vital for her extensive career in the pharmaceutical industry.
International and Market Experience
With over 25 years of experience in the pharmaceutical industry, Cristina Buraschi has extensive expertise in both the Italian and American markets. Her three-year tenure in New York has provided her with valuable international experience and insights into the global pharmaceutical landscape.